By proceeding, you agree to our Terms of Use and Privacy Policy.
Henry Hsu is currently Chief Executive Officer at Allysta Pharmaceuticals
Talks About #pharma #mediacal #health
Preferred Locations #NorthAmerica
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.